HOME >> BIOLOGY >> NEWS
A friendly foe -- Bacteria residing in the gut boost immune response to tumors

One potent, immune-based treatment for cancer is total body irradiation (TBI). This approach first depletes the body of the population of immune cells known as lymphocytes and then involves the adoptive transfer of tumor-specific T cells to the patient. Lymphodepletion has previously been shown to improve the ability of tumor-specific T cells to cause tumor regression. In a study appearing online on July 26 in advance of publication in the August print issue of the Journal of Clinical Investigation, Nicholas Restifo and colleagues from the National Cancer Institute show that, in mice, lymphodepletion does not fully account for the tumor regression observed following TBI. They show that a disruption of the population of bacteria that normally reside in the gut without causing disease also plays a role in the effectiveness of this therapeutic approach for cancer.

A specific population of bacteria present in our gut is crucial to our health. However, some treatments for cancer, particularly those that deplete the bodys immune cells, have high potential to disrupt the natural balance between our bodies and these commensal microorganisms, causing disease. Restifo and colleagues subjected mice genetically deficient in lymphocytes to TBI and found that, like TBI-treated mice with intact lymphocytes, TBI was still able to positively augment the function of adoptively transferred tumor-specific CD8+ T cells and cause tumor regression. This surprising result indicated that another mechanism for the efficacy of TBI also exists. They found that in these mutant, irradiated mice the lining of their gut was injured, allowing the passage of commensal bacteria from the gut to the lymph nodes, where the immune response to their presence increased the activation of tumor-specific CD8+ T cells and resulted in tumor regression. This effect was found to involve toll-like receptor 4. Conversely, a reduction in the number of host microorganisms by the use of antibiotics reduce
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
734-546-5242
Journal of Clinical Investigation
26-Jul-2007


Page: 1 2

Related biology news :

1. FSU pushing boundaries with environmentally friendly community
2. New Queens study offers environmentally friendly solution to oil industry needs
3. Eco-friendly bug sucker
4. Research shows Europeans prefer environmentally-friendly seafood
5. Switchable solvents make chemical manufacturing more environmentally-friendly
6. Chemical Society announces EPA awards for environmentally friendly technologies
7. Plant pathologists evaluate eco-friendly alternatives to methyl bromide
8. Fungus-friendly scientists meet in Tucson
9. Bacteria may not hasten death
10. Bacteria ferry nanoparticles into cells for early diagnosis, treatment
11. Bacteria show promise in fending off global amphibian killer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/6/2019)... , ... August 05, 2019 , ... ... is pleased to announce its attendance at the Microscopy & Microanalysis 2019 Meeting ... Oregon at the Oregon Convention Center. , The Microscopy & Microanalysis Meeting, organized ...
(Date:8/1/2019)... ... August 01, 2019 , ... The GENSPEED platform is ... care. It is fully developed with over 100 units deployed in the field ... fields of use, our collaboration with axiVEND will give us a foothold in the ...
(Date:8/1/2019)... ... July 31, 2019 , ... Advancements with Ted Danson to ... more information. , Factor Bioscience Inc. (Factor) is pioneering nucleic-acid and cell-based technologies ... This segment of Advancements will explore how Factor Bioscience is building the future ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... ... July 08, 2019 , ... Today, at the BIO World Congress ... Association (NCGA) announced the winners of the Consider Corn Challenge II. Three winners ... field corn to produce biobased materials. , “Corn is a sustainable, abundant and ...
(Date:6/26/2019)... ... 2019 , ... Alice Branton today released research results from preclinical trials on ... which can prove to be beneficial for treating Hypomagnesemia. , The preclinical trial shows:, ... crystallite size , Over 142% increase in particle size , ...
(Date:6/12/2019)... TOWNSHIP, N.J. (PRWEB) , ... June 12, 2019 ... ... of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device ... with Shanghai Zillion has been signed. The agreement will grant exclusive rights for ...
(Date:6/11/2019)... ... June 10, 2019 , ... DeepDyve ... of its scientific journals to DeepDyve’s rental service for peer-reviewed journals. , ... library of more than 20 million articles, sourced from more than 15,000 journals. ...
Breaking Biology Technology:
Cached News: